Lineage Cell Therapeutics (LCTX) Capital Leases (2014 - 2026)
Lineage Cell Therapeutics (LCTX) reported Capital Leases of $22000.0 for Q1 2026, down 56.86% on a YoY basis from $51000.0 in Q1 2025, and down 31.25% quarter-over-quarter from $32000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Capital Leases (2014 - 2026) Analysis & Trends
Lineage Cell Therapeutics has reported Capital Leases for 13 years, with the latest figure at $22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases fell 56.86% year-over-year to $22000.0; the trailing twelve-month figure through Mar 2026 stood at $22000.0 (down 56.86% YoY), and the FY2025 full-year result was $32000.0, down 52.24% from the prior year.
- Capital Leases for Q1 2026 stood at $22000.0, down from $32000.0 in the prior quarter.
- The five-year high for Capital Leases was $133000.0 in Q1 2023, with the low at $16000.0 in Q3 2022.
- Historically, Capital Leases has averaged $62705.9 across 5 years, with a median of $67000.0 in 2024.
- Annual changes were most pronounced in 2023 — Capital Leases jumped 506.25% — and 2026, when it tumbled 56.86%.
- Lineage Cell Therapeutics' Capital Leases stood at $84000.0 in 2022, then climbed by 8.33% to $91000.0 in 2023, then retreated by 26.37% to $67000.0 in 2024, then tumbled by 52.24% to $32000.0 in 2025, then plunged by 31.25% to $22000.0 in 2026.
- The last three Capital Leases figures came in at $22000.0 (Q1 2026), $32000.0 (Q4 2025), and $40000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 16,000.00 |